Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
[1] Cell Line:Cultured Sprague-Dawley rat Achilles tendon fibroblasts (passages 2-4) Concentration:0, 0.5, 1, 2 g/mL Incubation Time:24 h Result:Did not alter total FAK, paxillin, or PCNA protein levels
Some individuals may notice improvements within a few days to a week after receiving an injection or IV infusion
Both are safe when used right, but mixing them might cause problems for some
Luger, Are melanocortin peptides future therapeutics for cutaneous wound healing?, Wiley, Feb